BlueBee’s CEO Hans Cobben will be presenting at this year’s Nordic Precision Medicine Forum on the subject of “Precision Medicine: A data enabled reality”. He will also be leading a roundtable discussion entitled “Bound to co-exist: Population Genomics and Precision Medicine?”.
Precision medicine has grown to become a major field in recent years. Realizing that a medicine is particularly effective for populations with specific genetics allows doctors to tailor their treatment plans to maximize the benefit to individual patients on a case-by-case basis. Demand for precision medicine is growing as we learn more about the ways in which lifestyle, dietary and exercise habits impact on our ability to resist or recover from disease. In the developed world in particular, where the population is aging more rapidly, diseases such as cancer and dementia are becoming chronic, leading to a need for more precise diagnoses and treatment that offers greater efficiency.
However: precision medicine is ultimately powered by large quantities of patient data drawn from representative populations, and there are many challenges that still need to be overcome to ease access to and gain consent for such data in ways suitable for a mass clinical application. One of the key issues is making sense of the huge amounts of genomic data involved, with the volume generated expected to exceed the storage requirements of platforms such as YouTube and Twitter as early as 2025. The ability to effectively manage this data volume and maximize the speed of analysis are essential for precision medicine to become a reality.
These issues, and answers to them will be covered by Hans in his presentation on “Precision Medicine: A data enabled reality”, currently scheduled at 11.40am on 21st March.
His roundtable discussion on “Bound to co-exist: Population Genomics and Precision Medicine” will take place at 3.40pm the same day.
The Nordic Precision Medicine Forum is being held on 20th-21st March 2018 in Copenhagen, Denmark. Details of any late changes to the agenda can be found here.
Read an interview with Hans Cobben about enabling and facilitating the potential of precision medicine through data analysis. Interviewed by Precision Medicine Forum’s Editor, Mark Glover.